Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,990 | -20,233 | -9,529 | -4,107 | -14,214 |
| Depreciation Amortization | 896 | 477 | 259 | 123 | 265 |
| Accounts payable and accrued liabilities | 164 | -14 | 1,176 | 304 | 520 |
| Other Working Capital | 3,436 | 1,737 | 1,862 | 607 | 351 |
| Other Operating Activity | 3,006 | 2,119 | -20 | 244 | 3 |
| Operating Cash Flow | $-32,488 | $-15,913 | $-6,252 | $-2,830 | $-13,075 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,101 | -1,997 | -1,712 | -63 | -678 |
| Purchase Of Investment | -89,286 | -79,419 | -62,333 | -49,368 | N/A |
| Sale Of Investment | 18,058 | 5,675 | 1,471 | 1,471 | N/A |
| Investing Cash Flow | $-74,329 | $-75,741 | $-62,573 | $-47,960 | $-678 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 21,000 | 21,000 | N/A | N/A | 11,000 |
| Debt Repayment | -11,050 | -10,000 | N/A | N/A | -1,500 |
| Common Stock Issued | 51,589 | 51,587 | 51,587 | 51,585 | 51,017 |
| Common Stock Repurchased | N/A | -1 | -1 | -1 | N/A |
| Other Financing Activity | -180 | -1,205 | 0 | 0 | 8 |
| Financing Cash Flow | $61,359 | $61,381 | $51,586 | $51,583 | $60,525 |
| Beginning Cash Position | 51,804 | 51,804 | 51,804 | 51,804 | 5,032 |
| End Cash Position | 6,346 | 21,530 | 34,565 | 52,598 | 51,804 |
| Net Cash Flow | $-45,458 | $-30,274 | $-17,239 | $794 | $46,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,488 | -15,913 | -6,252 | -2,830 | -13,075 |
| Capital Expenditure | -3,117 | -1,997 | -1,712 | -63 | -688 |
| Free Cash Flow | -35,605 | -17,910 | -7,963 | -2,892 | -13,763 |